United Therapeutics (UTH) Q4 2021 Earnings Report
4 Followers
DE:UTH Q4 2021 EPS Results
- Actual EPS
- EUR 3.12
- Consensus EPS
- EUR 3.18
- Beat/Miss
- Missed by -EUR 0.06
- One Year Ago EPS
- EUR 1.95
DE:UTH Q4 2021 Revenue Results
- Actual Revenue
- EUR 368.92M
- Expected Revenue
- EUR 379.93M
- Beat/Miss
- Missed by -EUR 11.01M
- YoY Revenue Growth
- +7.87%
Earnings Announcement Details
- Quarter
- Q4 2021
- Date
- 02/24/2022
- Time
- Before Open
- Conference Call
- Thursday, February 24, 2022
DE:UTH Upcoming Earnings
United Therapeutics's next earnings date is estimated for February 24, 2027, based on past reporting schedules.
Q4 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:UTH Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 24, 2027 | 2026 (Q4) | 4.79- | 6.84 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | 5.345.07 | 6.36 | -20.25% (-1.29) | |
| Aug 05, 2026 | 2026 (Q2) | 6.106.46 | 5.7 | 13.42% (+0.76) | |
| May 06, 2026 | 2026 (Q1) | 6.225.17 | 5.89 | -12.22% (-0.72) | |
| Feb 25, 2026 | 2025 (Q4) | 6.346.84 | 5.5 | 24.39% (+1.34) | |
| Oct 29, 2025 | 2025 (Q3) | 6.506.36 | 5.68 | 12.05% (+0.68) | |
| Jul 30, 2025 | 2025 (Q2) | 6.485.70 | 5.2 | 9.57% (+0.50) | |
| Apr 30, 2025 | 2025 (Q1) | 5.955.89 | 5.48 | 7.46% (+0.41) | |
| Feb 26, 2025 | 2024 (Q4) | 5.695.50 | 3.87 | 41.97% (+1.63) | |
| Oct 30, 2024 | 2024 (Q3) | 5.805.68 | 4.78 | 18.77% (+0.90) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
